Dekker K A, Inagaki T, Gootz T D, Kaneda K, Nomura E, Sakakibara T, Sakemi S, Sugie Y, Yamauchi Y, Yoshikawa N, Kojima N
Central Research Division, Pfizer Pharmaceuticals, Inc., Aichi, Japan.
J Antibiot (Tokyo). 1997 Oct;50(10):833-9. doi: 10.7164/antibiotics.50.833.
Seven new phthalide compounds with anti-Helicobacter pylori activities were isolated from the basidiomycete Phanerochaete velutina CL6387. The two most potent phthalide compounds, CJ-12,954 and CJ-13,014, have MICs of 5 ng/ml. The structure-activity relationship shows that the presence of a spiroketal part in addition to the phthalide part, greatly enhances the activity. The phthalide compounds appear to be specific for H. pylori, since they did not show antibacterial activities when tested against a panel of other microorganisms.
从担子菌丝光薄盖伞CL6387中分离出七种具有抗幽门螺杆菌活性的新苯酞类化合物。两种活性最强的苯酞类化合物CJ - 12954和CJ - 13014的最低抑菌浓度为5纳克/毫升。构效关系表明,除了苯酞部分外,螺缩酮部分的存在大大增强了活性。这些苯酞类化合物似乎对幽门螺杆菌具有特异性,因为在对一组其他微生物进行测试时,它们没有显示出抗菌活性。